{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T06:38:02Z","timestamp":1772347082573,"version":"3.50.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,11]],"date-time":"2011-05-11T00:00:00Z","timestamp":1305072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-230x-11-52","type":"journal-article","created":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T06:46:08Z","timestamp":1305182768000},"source":"Crossref","is-referenced-by-count":51,"title":["Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole"],"prefix":"10.1186","volume":"11","author":[{"given":"Robert C","family":"Heading","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert","family":"M\u00f6nnikes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Tholen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,11]]},"reference":[{"key":"581_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-2036.2005.02531.x","volume":"22","author":"R Fass","year":"2005","unstructured":"Fass R, Shapiro M, Dekel R, Sewell J: Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease - where next?. Aliment Pharmacol Ther. 2005, 22: 79-94.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"581_CR2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1365-2036.2008.03897.x","volume":"29","author":"AS Raghunath","year":"2009","unstructured":"Raghunath AS, Hungin AP, Mason J, Jackson W: Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors. Aliment Pharmacol Ther. 2009, 29 (4): 431-9.","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 9","key":"581_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-2036.2004.02239.x","volume":"20","author":"WC Orr","year":"2004","unstructured":"Orr WC, Heading R, Johnson LF, Kryger M: Review article: sleep and its relationship to gastro-oesophageal reflux. Aliment Pharmacol Ther. 2004, 20 (Suppl 9): 39-46.","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 9","key":"581_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2036.2004.02237.x","volume":"20","author":"R Shaker","year":"2004","unstructured":"Shaker R, Brunton S, Elfant A, Golopol L, Ruoff G, Stanghellini V: Review article: impact of night-time reflux on lifestyle - unrecognized issues in reflux disease. Aliment Pharmacol Ther. 2004, 20 (Suppl 9): 3-13.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"581_CR5","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.cgh.2008.11.021","volume":"7","author":"LB Gerson","year":"2009","unstructured":"Gerson LB, Fass R: A systematic review of the definitions, prevalence, and response to treatment of nocturnal gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2009, 7 (4): 372-8.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"581_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-2982.2004.00581.x","volume":"17","author":"GR Locke","year":"2005","unstructured":"Locke GR, Zinsmeister AR, Fett SL, Melton LJ, Talley NJ: Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil. 2005, 17 (1): 29-34.","journal-title":"Neurogastroenterol Motil"},{"issue":"3","key":"581_CR7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1365-2036.2007.03366.x","volume":"26","author":"HK Jung","year":"2007","unstructured":"Jung HK, Halder S, McNally M, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ: Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population. Aliment Pharmacol Ther. 2007, 26 (3): 453-61.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"581_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1046\/j.1365-2036.2004.01861.x","volume":"19","author":"V Stanghellini","year":"2004","unstructured":"Stanghellini V, Armstrong D, M\u00f6nnikes H, Bardhan KD: Systematic review: do we need a new gastro-oesophageal reflux disease questionnaire?. Aliment Pharmacol Ther. 2004, 19 (5): 463-79.","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"581_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000101078","volume":"75","author":"D Armstrong","year":"2007","unstructured":"Armstrong D, M\u00f6nnikes H, Bardhan KD, Stanghellini V: The construction of a new evaluative GERD questionnaire--methods and state of the art. Digestion. 2007, 75 (Suppl 1): 17-24.","journal-title":"Digestion"},{"key":"581_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/bmj.316.7127.285","volume":"316","author":"M Roland","year":"1998","unstructured":"Roland M, Torgerson D: Understanding controlled trials: what are pragmatic trials?. BMJ. 1998, 316: 285-","journal-title":"BMJ"},{"key":"581_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1745-6215-10-37","volume":"10","author":"S Treweek","year":"2009","unstructured":"Treweek S, Zwarenstein M: Making trials matter: pragmatic and explanatory trials and the problem of applicability. Trials. 2009, 10: 37-","journal-title":"Trials"},{"key":"581_CR12","first-page":"47","volume":"47","author":"A Franke","year":"2009","unstructured":"Franke A, Singer MV, Dumitra\u015fcu DL: How general practitioners manage patients with irritable bowel syndrome. Data from a German urban area. Rom J Intern Med. 2009, 47: 47-53.","journal-title":"Rom J Intern Med"},{"key":"581_CR13","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.dld.2005.06.011","volume":"37","author":"M Bellini","year":"2005","unstructured":"Bellini M, Tosetti C, Costa F, Biagi S, Stasi C, Del Punta A, Monicelli P, Mumolo MG, Ricchiuti A, Bruzzi P, Marchi S: The general practitioner's approach to irritable bowel syndrome: from intention to practice. Dig Liver Dis. 2005, 37: 934-939.","journal-title":"Dig Liver Dis"},{"key":"581_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1053\/gast.1996.v111.pm8698230","volume":"111","author":"D Armstrong","year":"1996","unstructured":"Armstrong D, Bennett JR, Blum AL, Dent J, De Domvai FT, Galmiche JP, Lundell L, Margulies M, Richter JE, Spechler SJ, Tytgat GN, Wallin L: The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology. 1996, 111: 85-92.","journal-title":"Gastroenterology"},{"key":"581_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/gut.45.2.172","volume":"45","author":"LR Lundell","year":"1999","unstructured":"Lundell LR, Dent J, Bennett JR, Blum AR, Armstrong D, Galmiche JP, Johnson F, Hongo M, Richter JE, Spechler SJ, Tytgat GN, Wallin L: Endoscopic assessment of esophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999, 45: 172-80.","journal-title":"Gut"},{"issue":"1","key":"581_CR16","first-page":"37","volume":"13","author":"CW Howden","year":"2007","unstructured":"Howden CW, Blume SW, de Lissovoy G: Practice patterns for managing Helicobacter pylori infection and upper gastrointestinal symptoms. Am J Manag Care. 2007, 13 (1): 37-44.","journal-title":"Am J Manag Care"},{"key":"581_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2288-3-28","volume":"3","author":"M Godwin","year":"2003","unstructured":"Godwin M, Ruhland L, Casson I, MacDonald S, Delva D, Birtwhistle R, Lam M, Seguin R: Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity. BMC Med Res Methodol. 2003, 3: 28-","journal-title":"BMC Med Res Methodol"},{"key":"581_CR18","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000079707","volume":"69","author":"KD Bardhan","year":"2004","unstructured":"Bardhan KD, Stanghellini V, Armstrong D, Bergh\u00f6fer P, Gatz G, M\u00f6nnikes H: Evaluation of GERD symptoms during therapy. Part I: Development of the new GERD questionnaire ReQuest\u2122. Digestion. 2004, 69: 229-37.","journal-title":"Digestion"},{"key":"581_CR19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000079708","volume":"69","author":"H M\u00f6nnikes","year":"2004","unstructured":"M\u00f6nnikes H, Bardhan K, Stanghellini V, Bergh\u00f6fer P, Bethke TD, Armstrong D: Evaluation of GERD symptoms during therapy. Part II: Psychometric evaluation and validation of the new GERD questionnaire ReQuest\u2122. Digestion. 2004, 69: 238-44.","journal-title":"Digestion"},{"key":"581_CR20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1365-2036.2004.02194.x","volume":"20","author":"KD Bardhan","year":"2004","unstructured":"Bardhan KD, Stanghellini V, Armstrong D, Bergh\u00f6fer P, Gatz G, M\u00f6nnikes : International validation of ReQuest\u2122 in patients with endoscopy-negative gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2004, 20: 891-8.","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl V","key":"581_CR21","first-page":"A62","volume":"55","author":"V Stanghellini","year":"2006","unstructured":"Stanghellini V, Armstrong D, M\u00f6nnikes H, Bardan KD, Schmitt H, Teutsch I, Bergh\u00f6fer P, Fass R: Determination of GERD symptom threshold based on ReQuest\u2122 in an international population. Gut. 2006, 55 (Suppl V): A62-","journal-title":"Gut"},{"key":"581_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP: The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983, 67: 361-70.","journal-title":"Acta Psychiatr Scand"},{"key":"581_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1477-7525-1-29","volume":"1","author":"RP Snaith","year":"2003","unstructured":"Snaith RP: Commentary: The Hospital Anxiety and Depression Scale. Health Qual Life Outcomes. 2003, 1: 29-","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"581_CR24","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1365-2036.2008.03922.x","volume":"29","author":"G Holtmann","year":"2009","unstructured":"Holtmann G, Chassany O, Devault KR, Schmitt H, Gebauer U, Doerfler H, Malagelada JR: International validation of a health-related quality of life questionnaire in patients with erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2009, 29 (6): 615-25.","journal-title":"Aliment Pharmacol Ther"},{"key":"581_CR25","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1572-0241.2004.04151.x","volume":"99","author":"RB Williams","year":"2004","unstructured":"Williams RB, Szczesniak MM, Maclean JC, Brake HM, Cole IE, Cook IJ: Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis. Am J Gastroenterol. 2004, 99: 777-85.","journal-title":"Am J Gastroenterol"},{"key":"581_CR26","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1017\/S0022215108001898","volume":"122","author":"N Siupsinskiene","year":"2008","unstructured":"Siupsinskiene N, Adamonis K, Toohill RJ, Sereika R: Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal reflux patients. J Laryngol Otol. 2008, 122: 1206-12.","journal-title":"J Laryngol Otol"},{"key":"581_CR27","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1023\/B:DDAS.0000004513.27054.d0","volume":"48","author":"V Garrigues","year":"2003","unstructured":"Garrigues V, Gisbert L, Bastida G, Ortiz V, Bau I, Nos P, Ponce J: Manifestations of gastroesophageal reflux and response to omeprazole therapy in patients with chronic posterior laryngitis: an evaluation based on clinical practice. Dig Dis Sci. 2003, 48: 2117-23.","journal-title":"Dig Dis Sci"},{"key":"581_CR28","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1365-2036.2006.02983.x","volume":"24","author":"NJ Talley","year":"2006","unstructured":"Talley NJ, Armstrong D, Junghard O, Wiklund I: Predictors of treatment response in patients with non-erosive reflux disease. Aliment Pharmacol Ther. 2006, 24: 371-6.","journal-title":"Aliment Pharmacol Ther"},{"key":"581_CR29","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1185\/03007990903080931","volume":"25","author":"RC Orlando","year":"2009","unstructured":"Orlando RC, Monyak JT, Silberg DG: Predictors of heartburn resolution and erosive esophagitis in patients with GERD. Curr Med Res Opin. 2009, 25: 2091-102.","journal-title":"Curr Med Res Opin"},{"key":"581_CR30","volume-title":"Addison-Wesley","author":"J Tukey","year":"1977","unstructured":"Tukey J: Exploratory Data Analysis. Addison-Wesley. 1977"},{"issue":"suppl 1","key":"581_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000101020","volume":"75","author":"KD Bardhan","year":"2007","unstructured":"Bardhan KD, Bergh\u00f6fer P: Look - But Also Listen! ReQuest\u2122: An essay on a new validated scale to assess the outcome of GERD treatment. Digestion. 2007, 75 (suppl 1): 87-100.","journal-title":"Digestion"},{"key":"581_CR32","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/j.1365-2036.2010.04406.x","volume":"32","author":"H El Serag","year":"2010","unstructured":"El Serag H, Bechler A, Jones R: Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies. Aliment Pharmacol Ther. 2010, 32: 720-37.","journal-title":"Aliment Pharmacol Ther"},{"key":"581_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0140-6736(90)90287-F","volume":"335","author":"AG Klauser","year":"1990","unstructured":"Klauser AG, Schindlbeck NE, M\u00fcller-Lissner SA: Symptoms in gastro-oesophageal reflux disease. Lancet. 1990, 335: 205-8.","journal-title":"Lancet"},{"key":"581_CR34","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1136\/gut.2009.200063","volume":"59","author":"J Dent","year":"2010","unstructured":"Dent J, Vakil N, Jones R, Bytzer O, Sch\u00f6ning U, Halling K, Jughard O, Lind T: Accuracy of the diagnosis of GORD by questionnaire, physicians and trial of proton pump inhibitor treatment: the Diamond Study. Gut. 2010, 59: 714-21.","journal-title":"Gut"},{"issue":"Suppl 2","key":"581_CR35","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1038\/ajg.2009.50","volume":"104","author":"R Fass","year":"2009","unstructured":"Fass R: Proton pump inhibitor failure - what are the therapeutic options?. Am J Gastroenterol. 2009, 104 (Suppl 2): S33-8.","journal-title":"Am J Gastroenterol"},{"key":"581_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/gut.2007.145581","volume":"58","author":"R Fass","year":"2009","unstructured":"Fass R, Sifrim D: Management of heartburn not responding to proton pump inhibitors. Gut. 2009, 58: 295-309.","journal-title":"Gut"},{"issue":"Suppl 1","key":"581_CR37","first-page":"A","volume":"134","author":"H M\u00f6nnikes","year":"2008","unstructured":"M\u00f6nnikes H, Doerfler H, Schmitt H, Bergh\u00f6fer P, Heading R: Is the response of GERD patients to PPI therapy affected by the presence of IBS-like symptoms?. Gastroenterology. 2008, 134 (Suppl 1): A-126.","journal-title":"Gastroenterology"},{"key":"581_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-2036.2005.02531.x","volume":"22","author":"R Fass","year":"2005","unstructured":"Fass R, Shapiro M, Dekel R, Sewell J: Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease - where next?. Aliment Pharmacol Ther. 2005, 22: 79-94.","journal-title":"Aliment Pharmacol Ther"},{"key":"581_CR39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/01.mcg.0000225631.07039.6d","volume":"41","author":"R Fass","year":"2007","unstructured":"Fass R: Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroneterol. 2007, 41: 131-7.","journal-title":"J Clin Gastroneterol"},{"key":"581_CR40","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1007\/s10620-006-9306-y","volume":"51","author":"I Nastaskin","year":"2006","unstructured":"Nastaskin I, Mehdikhani E, Conklin J, Park S, Pimentel M: Studying the overlap between IBS and GERD: A systematic review of the literature. Dig Dis Sci. 2006, 51: 2113-20.","journal-title":"Dig Dis Sci"},{"key":"581_CR41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11894-006-0045-1","volume":"8","author":"R Dickman","year":"2006","unstructured":"Dickman R, Feroze H, Fass R: Gastroesophageal reflux disease and irritable bowel syndrome: A common overlap syndrome. Curr Gastroenterol Rep. 2006, 8: 261-5.","journal-title":"Curr Gastroenterol Rep"},{"key":"581_CR42","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/00004836-200203000-00004","volume":"34","author":"M Pimentel","year":"2002","unstructured":"Pimentel M, Rossi F, Chow EJ, Ofman J, Fullerton S, Hassard P, Lin HC: Increased prevalence of irritable bowel syndrome in patients with gastroesophageal reflux. J Clin Gastroenterol. 2002, 34: 221-4.","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"581_CR43","first-page":"251","volume":"54","author":"M Astegiano","year":"2008","unstructured":"Astegiano M, Pellicano R, Sguazzini C, Berrutti M, Simondi D, Reggiani S, Rizzetto M: Clinical approach to irritable bowel syndrome. Minerva Gastroenterol Dietol. 2008, 54 (3): 251-7.","journal-title":"Minerva Gastroenterol Dietol"},{"issue":"6","key":"581_CR44","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1136\/gut.43.6.770","volume":"43","author":"TM Kennedy","year":"1998","unstructured":"Kennedy TM, Jones RH, Hungin AP, O'flanagan H, Kelly P: Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut. 1998, 43 (6): 770-4.","journal-title":"Gut"},{"issue":"10","key":"581_CR45","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3748\/wjg.v16.i9.1232","volume":"16","author":"SS Yarandi","year":"2010","unstructured":"Yarandi SS, Nasseri-Moghaddam S, Mostajabi P, Malekzadeh R: Overlapping gastroesophageal reflux disease and irritable bowel syndrome: increased dysfunctional symptoms. World J Gastroenterol. 2010, 16 (10): 1232-8.","journal-title":"World J Gastroenterol"},{"key":"581_CR46","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000101085","volume":"75","author":"D Glatzel","year":"2007","unstructured":"Glatzel D, Abdel-Quader M, Gatz G, Pfaffenberger B: Pantoprazole 40 mg is as effective as esomeprazole 40 mg to relieve symptoms of gastroesophageal reflux disease after 4 weeks of treatment and superior regarding the prevention of symptomatic relapse. Digestion. 2007, 75: 69-78.","journal-title":"Digestion"},{"key":"581_CR47","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1159\/000101084","volume":"75","author":"H M\u00f6nnikes","year":"2007","unstructured":"M\u00f6nnikes H, Pfaffenberger B, Gatz G, Hein J, Bardhan KD: Novel measurement of rapid treatment success with ReQuest: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole. Digestion. 2007, 75: 62-8.","journal-title":"Digestion"},{"key":"581_CR48","first-page":"7","volume":"41","author":"V Stanghellini","year":"2005","unstructured":"Stanghellini V: ReQuest\u2122: new dimensions in the assessment and management of GERD. Drugs Today. 2005, 41: 7-11.","journal-title":"Drugs Today"},{"key":"581_CR49","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1365-2036.2008.03596.x","volume":"27","author":"B Nojkov","year":"2008","unstructured":"Nojkov B, Rubenstein JH, Adlis SA, Shaw MJ, Saad R, Rai J, Weinman B, Chey WD: The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2008, 27: 473-82.","journal-title":"Aliment Pharmacol Ther"},{"key":"581_CR50","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1053\/rmed.2001.1055","volume":"95","author":"T Kiljander","year":"2001","unstructured":"Kiljander T, Salomaa ER, Hietanen E, Helenius H, Liippo K, Terho EO: Asthma and gastro-oesophageal reflux: can the response to anti-reflux therapy be predicted?. Respir Med. 2001, 95: 387-92.","journal-title":"Respir Med"},{"issue":"8","key":"581_CR51","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1007\/s11605-009-0930-7","volume":"13","author":"S Ayazi","year":"2009","unstructured":"Ayazi S, Hagen JA, Chan LS, DeMeester SR, Lin MW, Ayazi A, Leers JM, Oezcelik A, Banki F, Lipham JC, DeMeester TR, Crookes PF: Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms. J Gastrointest Surg. 2009, 13 (8): 1440-7.","journal-title":"J Gastrointest Surg"},{"issue":"6","key":"581_CR52","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/j.1572-0241.2005.41703.x","volume":"100","author":"HB El-Serag","year":"2005","unstructured":"El-Serag HB, Graham DY, Satia JA, Rabeneck L: Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol. 2005, 100 (6): 1243-50.","journal-title":"Am J Gastroenterol"},{"issue":"22","key":"581_CR53","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1056\/NEJMoa054391","volume":"354","author":"BC Jacobson","year":"2006","unstructured":"Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA: Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med. 2006, 354 (22): 2340-8.","journal-title":"N Engl J Med"},{"issue":"1","key":"581_CR54","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.gtc.2009.12.002","volume":"39","author":"G Anand","year":"2010","unstructured":"Anand G, Katz PO: Gastroesophageal reflux disease and obesity. Gastroenterol Clin North Am. 2010, 39 (1): 39-46.","journal-title":"Gastroenterol Clin North Am"},{"issue":"22","key":"581_CR55","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1056\/NEJMoa054391","volume":"354","author":"C Jacobson","year":"2006","unstructured":"Jacobson C, Somers SC, Fuchs CS, Kelly CP, Camargo CA: Association Between Body Mass Index and Gastroesophageal Reflux Symptoms in Both Normal Weight and Overweight Women. N Engl J Med. 2006, 354 (22): 2340-8.","journal-title":"N Engl J Med"},{"key":"581_CR56","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1136\/gut.2010.228064","volume":"60","author":"J Fletcher","year":"2011","unstructured":"Fletcher J, Derakhshan MH, Jones GR, Wirz AA, McColl KE: BMI is superior to symptoms in predicting response to proton pump inhibitor: randomised trial in patients with upper gastrointestinal symptoms and normal endoscopy. Gut. 2011, 60: 442-8.","journal-title":"Gut"},{"key":"581_CR57","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1046\/j.1365-2036.1997.00246.x","volume":"11","author":"JG Hatlebakk","year":"1997","unstructured":"Hatlebakk JG, Berstad A: Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazole. Aliment Pharmacol Ther. 1997, 11: 1093-9.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"581_CR58","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1111\/j.1365-2036.2009.03962.x","volume":"29","author":"J Labenz","year":"2009","unstructured":"Labenz J, Armstrong D, Zetterstrand S, Eklund S, Leodolter A: Clinical trial: factors associated with resolution of heartburn in patients with reflux oesophagitis--results from the EXPO study. Aliment Pharmacol Ther. 2009, 29 (9): 959-66.","journal-title":"Aliment Pharmacol Ther"},{"key":"581_CR59","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/j.1365-2036.2008.03683.x","volume":"27","author":"O Chassany","year":"2008","unstructured":"Chassany O, Holtmann G, Malagelada J, Gebauer U, Doerfler H, Devault K: Systematic review: health-related quality of life (HRQOL) questionnaires in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2008, 27: 1053-70.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"581_CR60","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1365-2036.2005.02558.x","volume":"22","author":"F Pace","year":"2005","unstructured":"Pace F, Negrini C, Wiklund I, Rossi C, Savarino V, Italian One Investigators Study Group: Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2005, 22 (4): 349-56.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"581_CR61","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1365-2036.2008.03921.x","volume":"29","author":"M Nocon","year":"2009","unstructured":"Nocon M, Labenz J, Jaspersen D, Leodolter A, Richter K, Vieth M, Lind T, Malfertheiner P, Willich SN: Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD study. Aliment Pharmacol Ther. 2009, 29 (6): 662-8.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"581_CR62","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1023\/A:1026458604826","volume":"6","author":"RJ Stephens","year":"1997","unstructured":"Stephens RJ, Hopwood P, Girling DJ, Machin D: Randomized trials with quality of life endpoints: are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings?. Qual Life Res. 1997, 6 (3): 225-36.","journal-title":"Qual Life Res"},{"key":"581_CR63","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1572-0241.2005.40945.x","volume":"100","author":"E McColl","year":"2005","unstructured":"McColl E, Junghard O, Wiklund I, Revicki DA: Assessing symptoms in gastroesophageal reflux disease: how well do clinicians' assessments agree with those of their patients?. Am J Gastroenterol. 2005, 100: 11-8.","journal-title":"Am J Gastroenterol"},{"issue":"15","key":"581_CR64","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1001\/jama.1995.03520390045031","volume":"273","author":"RF Nease Jr","year":"1995","unstructured":"Nease RF, Kneeland T, O'Connor GT, Sumner W, Lumpkins C, Shaw L, Pryor D, Sox HC: Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. Ischemic Heart Disease Patient Outcomes Research Team. JAMA. 1995, 273 (15): 1185-90. Erratum in: JAMA 1995, 274(8):612","journal-title":"JAMA"},{"key":"581_CR65","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/j.1365-2036.2004.02165.x","volume":"20","author":"JY Kang","year":"2004","unstructured":"Kang JY: Systematic review: geographical and ethnic differences in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2004, 20: 705-17.","journal-title":"Aliment Pharmacol Ther"},{"key":"581_CR66","first-page":"751","volume":"20","author":"G Rubin","year":"2008","unstructured":"Rubin G, Uebel P, Brimo-Hayek A, Hey KH, Doerfler H, Heading RC: Validation of a brief symptom questionnaire (ReQuest in Practice\u2122) for patients with gastroesophageal reflux disease (GERD). Aliment Pharmacol Ther. 2008, 20: 751-60.","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl III","key":"581_CR67","first-page":"A214","volume":"56","author":"G Rubin","year":"2007","unstructured":"Rubin G, Doerfler H, Korell A, Heading RC: A short symptom questionnaire can improve decision making in the step-down management of gastro-esophageal-reflux disease (GERD). Gut. 2007, 56 (Suppl III): A214-","journal-title":"Gut"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-11-52\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-11-52.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-11-52","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-11-52.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T12:51:52Z","timestamp":1548247912000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-11-52"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,11]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["581"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-11-52","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,11]]},"article-number":"52"}}